explore -WSS

explore

author：knowledge 2025-09-30 00:10:18 - browse：3

James Comer (R-KY) walks on the House side of the U.S. Capitol on May 14, 2024 in Washington, DC — Rep. James Comer (R-Ky.), the chair of the House Committee on Oversight and Accountability, has taken an interest in pharmacy benefit managers. Kent Nishimura/Getty Images

WASHINGTON — Executives from the three major pharmacy benefit manager companies have been invited to testify before the House Committee on Oversight and Accountability next month, four sources familiar with the planning told STAT.

Executives from Optum, CVS Caremark, and Express Scripts, owned by Cigna, were asked to testify before the panel on June 4.

The committee and companies did not respond to requests for comment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Montana youths win climate lawsuit against state for promoting fossil fuels

WSS

Health AI: on the border between health care and tech

Senators push IRS to launch nonprofit hospital probe

Idaho college killings prosecutors challenge defense's grand jury claims

What to know about the judge who will handle the Trump case

Digital health: a case of mistaken identity

Aspartame and sugar

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Digital health: a case of mistaken identity

DIEP, the 'gold standard' of breast reconstruction, is under threat

Bird flu researchers hone in on Finland’s mink farms

What does generative AI mean for health care? We asked experts

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

After affirmative action ruling, medical educators look to 'holistic review'

Biden administration begins canceling student loan debt for 804,000 borrowers

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Maui wildfire now ranks as the fifth

focus

Biogen’s boardroom scandal saddles CEO with first crisis

Dozens dead from Maui wildfires: What we know about the victims

Investigation reveals sickle cell patients pressured into sterilizations

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

BMS, looking to build heart drug business, turns to AI for diagnosis

Digital health: a case of mistaken identity

Wikipedia

leisure time

focus

focus